Economic evaluations of follow-up strategies for cancer survivors: a systematic review and quality appraisal of the literature

Expert Rev Pharmacoecon Outcomes Res. 2015;15(6):913-29. doi: 10.1586/14737167.2015.1087316. Epub 2015 Oct 8.

Abstract

The aim of this study was to review and critically assess the health economics literature on post-treatment follow-up for adult cancer survivors. A systematic search was performed using PubMed, EMBASE and the Cochrane Library. The Consolidated Health Economic Evaluation Reporting Standards checklist was adopted to assess the quality of the included studies. Thirty-nine articles met the eligibility criteria. Around two thirds of the studies addressed the most common cancers (i.e., breast, colorectal, cervical and lung); 21 were based on a single clinical study, while the rest were modeling papers. All types of economic evaluations were represented other than cost-benefit analysis. The overall quality was generally high with an average proportion of 74% of checklist criteria fulfilled. The cost-effectiveness results supported the current trend towards less intensive, primary care-based and risk-adapted follow-up schemes.

Keywords: Consolidated Health Economic Evaluation Reporting Standards; cancer; cost-effectiveness; economic evaluation; follow-up; quality; review.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Adult
  • Aftercare / economics*
  • Checklist
  • Cost-Benefit Analysis
  • Humans
  • Models, Economic
  • Neoplasms / economics
  • Neoplasms / pathology
  • Neoplasms / rehabilitation*
  • Primary Health Care / economics
  • Survivors*